TVWM
MRNA icon

Tower View Wealth Management’s Moderna MRNA Stock Holding History

Tower View Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3
Closed – – 187
2023
Q2 		$0 Hold
3
– – ﹤0.01% 186
2023
Q1 		$0 Hold
3
– – ﹤0.01% 159
2022
Q4 		$1K Hold
3
– – ﹤0.01% 158
2022
Q3 		$0 Hold
3
– – ﹤0.01% 172
2022
Q2 		$0 Sell
3
-1
-25% -$143 ﹤0.01% 189
2022
Q1 		$1K Hold
4
– – ﹤0.01% 180
2021
Q4 		$1K Hold
4
– – ﹤0.01% 186
2021
Q3 		$2K Hold
4
– – ﹤0.01% 213
2021
Q2 		$1K Sell
4
-3
-43% -$536 ﹤0.01% 168
2021
Q1 		$1K Buy
+7
New +$1.01K ﹤0.01% 183

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Tower View Wealth Management's MRNA Position: Q3 2023 in Review

Tower View Wealth Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 3 shares.

Tower View Wealth Management first reported a position in MRNA in Q1 2021 and held it in 10 quarters. The position peaked at $2K in Q3 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Tower View Wealth Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Tower View Wealth Management sold 3 Moderna shares in Q3 2023.
  • Tower View Wealth Management first reported a position in Moderna in Q1 2021 and held it in 10 quarters.
  • Tower View Wealth Management's Moderna position peaked at $2K in Q3 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Tower View Wealth Management's 13F filing for Q3 2023, filed 31 Oct 2023.